These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 619742)

  • 21. [Evaluation of the effectiveness and toxicity of pentostam and glucantime in the treatment of cutaneous leishmaniasis].
    Sáenz RE; Paz HM; Johnson CM; Narvaez E; de Vásquez AM
    Rev Med Panama; 1987 Sep; 12(3):148-57. PubMed ID: 2827242
    [No Abstract]   [Full Text] [Related]  

  • 22. [Kala-azar and autoimmune hemolytic anemia. Apropos of a fatally developing case caused by hepatotoxicity from N-methylglucamine antimonate].
    De Pablos Gallego JM; Cabrera Torres A; Almagro M; De Puerta S; López Garrido P; Gómez Morales M; Esquivias JJ
    Rev Clin Esp; 1982 Mar; 164(6):417-20. PubMed ID: 7111811
    [No Abstract]   [Full Text] [Related]  

  • 23. [Complications and diagnostic value of Dimer-X myelography].
    Seeber E
    Beitr Orthop Traumatol; 1981 Jul; 28(7):395-400. PubMed ID: 7295277
    [No Abstract]   [Full Text] [Related]  

  • 24. Side-effects at phlebography with ionized and non-ionized contrast medium.
    Albrechtsson U
    Diagn Imaging; 1979; 48(4):236-40. PubMed ID: 498920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Late meningeal changes after dimer-X-myelography in the absence of surgery (author's transl)].
    Assmann H; Besel R; Schumann E; Usbeck W
    Rofo; 1981 Apr; 134(4):422-5. PubMed ID: 6453059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Perfusion cholangiocholecystography with a new contrast medium: contrastographic results as a function of different infusion rates].
    Mascheroni F; Improta G; Poma A
    Clin Ter; 1979 Mar; 88(5):509-16. PubMed ID: 466972
    [No Abstract]   [Full Text] [Related]  

  • 27. Placebo-controlled clinical trial of meglumine antimonate (glucantime) vs. localized controlled heat in the treatment of cutaneous leishmaniasis in Guatemala.
    Navin TR; Arana BA; Arana FE; de Mérida AM; Castillo AL; Pozuelos JL
    Am J Trop Med Hyg; 1990 Jan; 42(1):43-50. PubMed ID: 2405727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case of meglumine iodipamide hepatotoxicity.
    Motoki T; Ikeuchi M; Hirano M; Yatsuji Y; Murao S
    Am J Gastroenterol; 1979 Jul; 72(1):71-4. PubMed ID: 463851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disulfiram hepatotoxicity.
    Ranek L; Buch Andreasen P
    Br Med J; 1977 Jul; 2(6079):94-6. PubMed ID: 871808
    [No Abstract]   [Full Text] [Related]  

  • 30. [Tolerance and contrast density in intravenous cholangiography and cholecystography using a new contrast medium (author's transl)].
    Siemers M; Schäfer K; Menges G; Horst H
    Rontgenblatter; 1978 Oct; 31(10):596-9. PubMed ID: 581525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunotherapy versus chemotherapy in localised cutaneous leishmaniasis.
    Convit J; Castellanos PL; Rondon A; Pinardi ME; Ulrich M; Castes M; Bloom B; Garcia L
    Lancet; 1987 Feb; 1(8530):401-5. PubMed ID: 2880213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatotoxicity of glafenine.
    Ypma RT; Festen JJ; De Bruin CD
    Lancet; 1978 Aug; 2(8087):480-1. PubMed ID: 79852
    [No Abstract]   [Full Text] [Related]  

  • 33. Thalidomide-induced severe hepatotoxicity.
    Dabak V; Kuriakose P
    Cancer Chemother Pharmacol; 2009 Mar; 63(4):583-5. PubMed ID: 19083237
    [No Abstract]   [Full Text] [Related]  

  • 34. Erythromycin ethylsuccinate hepatotoxicity.
    Sullivan D; Csuka ME; Blanchard B
    JAMA; 1980 Mar; 243(10):1074. PubMed ID: 6965509
    [No Abstract]   [Full Text] [Related]  

  • 35. Hepatotoxicity of antituberculous drugs.
    Rao NK; Wadia RS; Karve SR; Grant KB
    J Assoc Physicians India; 1982 May; 30(5):295-8. PubMed ID: 7169440
    [No Abstract]   [Full Text] [Related]  

  • 36. FK506 hepatotoxicity in liver allograft recipients.
    Fisher A; Mor E; Hytiroglou P; Emre S; Boccagni P; Chodoff L; Sheiner P; Schwartz M; Thung SN; Miller C
    Transplantation; 1995 Jun; 59(11):1631-2. PubMed ID: 7539961
    [No Abstract]   [Full Text] [Related]  

  • 37. Febrile reaction to methlydopa with hepatotoxicity.
    Miller JP
    Va Med Mon (1918); 1970 Mar; 97(3):159-62. PubMed ID: 5528092
    [No Abstract]   [Full Text] [Related]  

  • 38. Hepatotoxicity due to methylphenidate hydrochloride.
    Goodman CR
    N Y State J Med; 1972 Sep; 72(18):2339-40. PubMed ID: 4506888
    [No Abstract]   [Full Text] [Related]  

  • 39. Hepatotoxicity of papaverine.
    Kiaer HW; Olsen S; Ronnov-Jessen V
    Arch Pathol; 1974 Nov; 98(5):292-6. PubMed ID: 4413667
    [No Abstract]   [Full Text] [Related]  

  • 40. Amiodarone hepatotoxicity.
    Elving LD; Hoefnagels WH; Van Haelst UJ; Griffioen G; Janssens AR; Ruiter DJ
    Neth J Med; 1986; 29(10):303-7. PubMed ID: 3796766
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.